RT Journal Article
SR Electronic
T1 Durable response rate as an endpoint in cancer immunotherapy: insights from oncolytic virus clinical trials
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP 72
DO 10.1186/s40425-017-0276-8
VO 5
IS 1
A1 Kaufman, Howard L.
A1 Andtbacka, Robert H. I.
A1 Collichio, Frances A.
A1 Wolf, Michael
A1 Zhao, Zhongyun
A1 Shilkrut, Mark
A1 Puzanov, Igor
A1 Ross, Merrick
YR 2017
UL http://jitc.bmj.com/content/5/1/72.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.